Sana investors have opportunity to lead sana biotechnology, inc. securities fraud lawsuit

New york , april 13, 2025 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of sana biotechnology, inc. (nasdaq: sana) between march 17, 2023 and november 4, 2024, both dates inclusive (the "class period"), of the important may 20, 2025 lead plaintiff deadline. so what: if you purchased sana securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
SANA Ratings Summary
SANA Quant Ranking